594 - A Phase I, Multicenter, Randomized, Double-blind, Placebo-controlled Single Dose, Dose-ranging Study to Evaluate the Safety, Tolerability, and Immunogenicity of Orally Administered Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females ≥ 18 years Old and Their Breast-feeding Infants

Saturday, October 19, 2024

2:15 PM – 2:30 PM US PT

Location: 403 B

Presenting Author(s)

Lam Nguyen, MD (she/her/hers)

Associate Medical Director of Pharmacovigilance
Vaxart Inc
Rancho Palos Verdes, CA, United States

Slides

Co-Author(s)

SG

Susan Greco, MD, MPH

Sr Medical Director
Vaxart, Inc
South San Francisco, California, United States
Becca A. Flitter, PhD, MPH

Senior Scientist
Vaxart Inc
South San Francisco, California, United States
MB

Molly Braun, PhD

Senior Scientist
Vaxart, Inc
South San Francisco, California, United States
ND

Nicholas D’Amato, MSc.

Nicholas P. D’Amato
Vaxart
South San Francisco, California, United States
ST

Sean N. Tucker, PhD

CSO, VP of Research
Vaxart
South San Francisco, California, United States
JC

James F. Cummings, MD

Chief Medical Officer
VAXART
South San Francisco, California, United States
CL

Colin A. Lester, n/a

Research Associate III
Vaxart, Inc.
South San Francisco, California, United States
DH

Darreann Carmela Hailey, MS

Vaxart, Inc.
South San Francisco, California, United States

Disclosure(s):

Lam Nguyen, MD: CVS Health: Stocks/Bonds (Public Company); Vaxart: Author is either employed and/or has received stock options from Vaxart as part of this work., Stocks/Bonds (Public Company)

Susan Greco, MD, MPH: Vaxart, Inc: Stocks/Bonds (Public Company)

Becca A. Flitter, PhD, MPH: Vaxart Inc: Stocks/Bonds (Public Company)

Molly Braun, PhD: Vaxart, Inc: Stocks/Bonds (Public Company), TREATMENT OF LONG COVID WITH ORALLY AND MUCOSALLY ADMINISTERED ADENOVIRAL VECTORS

Nicholas D’Amato, MSc.: Vaxart Inc.: Stocks/Bonds (Public Company)

Sean N. Tucker, PhD: Vaxart, Inc.: Grant/Research Support, Ownership Interest, patent, Stocks/Bonds (Public Company)

James F. Cummings, MD: VAXART: Stocks/Bonds (Public Company)

Colin A. Lester, n/a: Vaxart, Inc.: Stocks/Bonds (Public Company)

Darreann Carmela Hailey, MS: Bionano Genomics: Stocks/Bonds (Public Company); Vaxart, Inc.: Stocks/Bonds (Public Company)